Результати пошуку - Emma Link

  • Показ 1 - 10 результатів із 10
Уточнити результати
  1. 1
    Current Hepatitis B Screening Practices and Clinical Experience of Reactivation in Patients Undergoing Chemotherapy for Solid Tumors: A Nationwide Survey of Medical Oncologists

    Current Hepatitis B Screening Practices and Clinical Experience of Reactivation in Patients Undergoing Chemotherapy for Solid Tumors: A Nationwide Survey of Medical Oncologists за авторством Fiona Day, Emma Link, Karin Thursky, Danny Rischin

    Опубліковано 2011
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Improving Patient Selection for <sup>18</sup>F-FDG PET Scanning in the Staging of Gastric Cancer

    Improving Patient Selection for <sup>18</sup>F-FDG PET Scanning in the Staging of Gastric Cancer за авторством Yui Kaneko, William K. Murray, Emma Link, Rodney J. Hicks, Cuong Duong

    Опубліковано 2015
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study

    Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study за авторством Jemma C. Hopewell, Sarah Parish, Alison Offer, Emma Link, Robert Clarke, Mark Lathrop, Jane Armitage, Rory Collins

    Опубліковано 2012
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    <i>SLCO1B1</i>Variants and Statin-Induced Myopathy — A Genomewide Study

    <i>SLCO1B1</i>Variants and Statin-Induced Myopathy — A Genomewide Study за авторством Emma Link, Sarah Parish, Jane Armitage, Louise Bowman, Simon Heath, Fumihiko Matsuda, Marta Gut, Mark Lathrop, Rory Collins

    Опубліковано 2008
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma

    Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma за авторством Mizue Terai, Eric Londin, Ankit Rochani, Emma Link, Bao Lam, Gagan Kaushal, Alok Bhushan, Marlana Orloff, Takami Sato

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data

    Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data за авторством D. Gregory, Rodney J. Hicks, Annette Hogg, David Binns, Poh Lin Shum, Alvin Milner, Emma Link, David Ball, Michael P. Mac Manus

    Опубліковано 2012
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

    FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy за авторством Fiona Day, Emma Link, Samuel Y. Ngan, Trevor Leong, Kate Moodie, Craig Lynch, Michael Michael, Emma De Winton, Annette Hogg, Rodney J. Hicks, Alexander G. Heriot

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in<i>BRAF</i>V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

    A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in<i>BRAF</i>V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combina... за авторством Lavinia Tan, Ben Tran, Jeanne Tie, Ben Markman, Sumi Ananda, Niall C. Tebbutt, Michael Michael, Emma Link, Stephen Q. Wong, Sushma Chandrashekar, Jerick Guinto, David Ritchie, Rachel Koldej, Benjamin Solomon, Grant A. McArthur, Rodney J. Hicks, Peter Gibbs, Sarah‐Jane Dawson, Jayesh Desai

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

    First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study за авторством Amit Khot, Natalie Brajanovski, Donald P. Cameron, Nadine Hein, Kylee Maclachlan, Elaine Sanij, John K. C. Lim, John Soong, Emma Link, Piers Blombery, Ella R. Thompson, Andrew Fellowes, Karen E. Sheppard, Grant A. McArthur, Richard B. Pearson, Ross D. Hannan, Gretchen Poortinga, Simon J. Harrison

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

    Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3... за авторством Boon Chua, Emma Link, Ian Kunkler, Timothy J. Whelan, A. Helen Westenberg, Guenther Gruber, Guy Bryant, Verity Ahern, Kash Purohit, Peter Graham, Mohamed Akra, Orla McArdle, Peter C. O’Brien, Jennifer A. Harvey, Carine Kirkove, John H. Maduro, Ian Campbell, Geoff P. Delaney, Joseph D. Martin, T Trinh T Vu, Thierry Muanza, Anthony Neal, Ivo A. Olivotto

    Опубліковано 2022
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: